![](https://rutherford-public-images.imgix.net/channels/logo_images/c62d4e36ab8e56a5a12b1d310e73d01d.jpg?auto=format&fit=crop&h=112&w=112)
HTN : RDN : NOW
Ready to Practice
An international resource for the adoption of Renal Denervation in the fight against Hypertension.
This channel aims to give hypertension specialists and GPs everything required to explore and deploy Renal Denervation in patient practice. Learn from RDN practitioners in your markets, in your own languages, with a range of scientific and practical information; and build collaborations with peers that sustain the successful use of this ground-breaking complimentary therapy.
This is channel is supported by an educational grant from Medtronic.
An international resource for the adoption of Renal Denervation in the fight against Hypertension.
This channel aims to give hypertension specialists and GPs everything required to explore and deploy Renal Denervation in patient practice. Learn from RDN practitioners in your markets, in your own languages, with a range of scientific and practical information; and build collaborations with peers that sustain the successful use of this ground-breaking complimentary therapy.
This is channel is supported by an educational grant from Medtronic.
![](https://rutherford-public-images.imgix.net/channels/page_images/f36c3fdf412eab784ad08181720540b8.jpg?w=2048)
Latest Updates
What do the guidelines say?
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/3cbab22a-9d29-4133-a8fb-e8495379b733.png?auto=format&dpr=1)
The guidelines upgraded Renal Denervation to class 2 , which means RDN can be used in certain patients with uncontrolled blood pressure
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/48b6e0f9-2c1e-469b-94a9-1ed16a303ed7.png?auto=format&dpr=1)
The guidelines help us improve our practice, to fight the major problem in hypertension management which is poor patient adherence
Safety, Significance, Sustainability
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/6c518e24-6b5b-4f7e-98a6-8f7c43ff0ed1.png?auto=format&dpr=1)
Among all trials, renal denervation has achieved relevant reductions in blood pressure against the background of an excellent safety profile
Patient selection
![](https://reachora-public-videos.imgix.net/v/12/e/6/7153bc-aef7-4675-b068-0cfb96f49a5c/thumbnails/image_1.jpg?auto=format&dpr=1)
RDN:FDA | Patient Selection - An Interview with Dr. Taisei Kobayashi & Dr. Debbie Cohen
![HTN:RDN](https://rutherford-public-images.imgix.net/channels/logo_images/c62d4e36ab8e56a5a12b1d310e73d01d.jpg?auto=format&fit=crop&h=16&w=16)
HTN:RDN
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/91bff76e-9378-49bc-b77f-b04e88ecb8f0.png?auto=format&dpr=1)
The consensus paper shows that the therapy works on the top of drugs, and in patients without drugs
Patient Preference – Shared Decision Making
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/335896c1-7130-46a0-8aa3-f3c8dd20ef49.png?auto=format&dpr=1)